Should you buy Viatris stock? (NASDAQ:VTRS). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Viatris to reach your target.
| Advantages | Disadvantages |
|---|---|
|
|
| VTRS Price (Viatris stock price per share) |
$16.50 | |
| PE Ratio versus Sector | 26% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 0% lower than other Drug Manufacturers - General stocks | |
| Dividend Yield | 3% (tax impact) | Shares Shorted | 37,018,623 |
Open-market buys and sells reported by Viatris's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2024-11-11T00:00:00 | Campbell Paul (See Remarks) | Sell | 26,925 | $12.88 |
| 2024-09-12T00:00:00 | Malik Rajiv | Sell | 139,681 | $11.66 |
| 2024-09-12T00:00:00 | Malik Rajiv | Sell | 60,319 | $11.71 |
| 2024-08-30T00:00:00 | Malik Rajiv | Sell | 50,000 | $12.00 |
| 2024-08-28T00:00:00 | Malik Rajiv | Sell | 50,000 | $11.90 |
| 2024-08-23T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.75 |
| 2024-08-22T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.73 |
| 2024-08-21T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.75 |
| 2024-06-14T00:00:00 | Malik Rajiv | Sell | 264,300 | $10.18 |
| 2024-06-13T00:00:00 | Malik Rajiv | Sell | 85,660 | $10.52 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 37,018,623 shares shorted. With 1,141,791,206 shares available for purchase and an average trading volume over the past 10 trading days of 7,358,810, it would take at least 5.031 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Based on our analysis, we believe that you should not buy Viatris right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Advertisement supports free stock analysis content.
Does Viatris have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
We don't yet have enough financial history for Viatris to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.
Most Popular Articles
What is Self-Directed Investing?
DCA vs Lump Sum: 155 Years of S&P 500 Historical Data
Is Dogecoin a Good Investment? (2026)
What Happened to the Stock Market Today?
How Do Stock Brokers Make Money?
What Does COVID-19 Mean for Stocks?